iMDx kidney transplant test featured in Lancet study, gets Medicare nod

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. SPY
2. WBD
3. PSKY
4. NVDA
5. TSLA
6. USO
7. AMD
8. COHR
9. AMC
10. META

Go back to iMDx kidney transplant test featured in Lancet study, gets Medicare nod
(NASDAQ: IMDX) Delayed: 4.01 +0.01 (0.25%)
Previous Close $4.00    52 Week High $ 
Open $4.09    52 Week Low $ 
Day High $4.13    P/E N/A 
Day Low $3.84    EPS $ 
Volume 253,950